345 results
Page 7 of 18
8-K
EX-99.1
dlzqmq3oup 9n
30 Oct 19
Insmed Reports Third Quarter 2019 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
s2y40qd3cfs3iehl
1 Aug 19
Insmed Reports Second Quarter 2019 Financial Results and Provides Business Update
7:31am
8-K
EX-99.1
5mj3k4z8qzj 1yijuj8e
24 May 19
Insmed Announces Closing of Public Offering of Common Stock
11:35am
8-K
EX-99.1
j3q kcdf2e5t
24 May 19
Insmed Announces Proposed Public Offering of Common Stock
6:01am
8-K
EX-99.2
1g4j1enh
24 May 19
Insmed Announces Proposed Public Offering of Common Stock
6:01am
8-K
EX-1.1
pd78200il 0dtay
24 May 19
Insmed Announces Proposed Public Offering of Common Stock
6:01am
424B5
zyulwu
23 May 19
Prospectus supplement for primary offering
12:00am
424B5
rtoit jzf
20 May 19
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
atizdq jevjdminqvrm
7 May 19
Insmed Reports First Quarter 2019 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
q3q1i6cbtx6u8ap 4n13
8 Apr 19
Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch
9:08am
DEFA14A
t0df63zp o9k6
4 Apr 19
Additional proxy soliciting materials
4:07pm
8-K
EX-99.1
2s3l 75m87ge
22 Feb 19
Insmed Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
7:31am
8-K
EX-99.1
okxc7fq gd
7 Jan 19
Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch and Outlines Strategic Priorities for 2019
8:00am
8-K
EX-99.2
3ag5u0bpav33532
7 Jan 19
Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch and Outlines Strategic Priorities for 2019
8:00am